1,2-Ethanediamine, N1,N1,N2-trimethyl- → 4-[(5,7-Difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-N-[2-(dimethylamino)ethyl]-N,2-dimethyl-1H-benzimidazole-6-carboxamide
Reaktionsgleichung
[F:1][C:2]1[CH:11]=[C:10]([F:12])[CH:9]=[C:8]2[C:3]=1[CH:4]([O:13][C:14]1[C:22]3[N:21]=[C:20]([CH3:23])[NH:19][C:18]=3[CH:17]=[C:16]([C:24]([OH:26])=O)[CH:15]=1)[CH2:5][CH2:6][O:7]2.[CH3:27][N:28]([CH3:33])[CH2:29][CH2:30][NH:31][CH3:32]>>[F:1][C:2]1[CH:11]=[C:10]([F:12])[CH:9]=[C:8]2[C:3]=1[CH:4]([O:13][C:14]1[C:22]3[N:21]=[C:20]([CH3:23])[NH:19][C:18]=3[CH:17]=[C:16]([C:24]([N:31]([CH2:30][CH2:29][N:28]([CH3:33])[CH3:27])[CH3:32])=[O:26])[CH:15]=1)[CH2:5][CH2:6][O:7]2Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
The title compound was prepared as a white solid (10 mg, 13% yield for 3 steps) from 4-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-2-methyl-1H-benzimidazole-6-carboxylic acid (100 mg, crude, STEP 4 in Example 4) and N,N,N′-trimethyl-1,2-ethanediamine (45 mg, 0.44 mmol) by the same manner in STEP 5 of Example 1.